Restricted stock grant to Hanover Bancorp (HNVR) Chief Risk Officer

Rhea-AI Filing Summary

Hanover Bancorp, Inc. reported that its EVP & Chief Risk Officer, John P. Vivona, received a grant of 1,338 shares of common stock on February 5, 2026. The shares were granted at a price of $0.0000 per share as restricted stock subject to forfeiture.

The grant vests over three years, with one-third of the shares vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Vivona beneficially owns 5,247 shares of Hanover Bancorp common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Vivona John P

Role EVP & Chief Risk Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,338	$0.00	--

Holdings After Transaction: Common Stock — 5,247 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vivona John P

(Last) (First) (Middle)

C/O HANOVER BANCORP, INC.

80 EAST JERICHO TURNPIKE

(Street)

MINEOLA NY 11501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hanover Bancorp, Inc. /MD [ HNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		A		1,338(1)	A	$0.0000	5,247	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ John P. Vivona	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hanover Bancorp (HNVR) report for John P. Vivona?

Hanover Bancorp reported a grant of 1,338 shares of common stock to EVP & Chief Risk Officer John P. Vivona. The award is in the form of restricted stock granted at $0.0000 per share, increasing his direct beneficial ownership to 5,247 shares.

How many Hanover Bancorp (HNVR) shares does John P. Vivona own after this grant?

After the reported grant, John P. Vivona beneficially owns 5,247 shares of Hanover Bancorp common stock. This total reflects the addition of 1,338 restricted shares awarded on February 5, 2026, which will vest over a three-year schedule.

What are the vesting terms of the 1,338 restricted shares at Hanover Bancorp (HNVR)?

The 1,338 restricted shares vest over three years, with one-third vesting on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029. The shares are subject to forfeiture until they vest.

What role does the reporting person hold at Hanover Bancorp (HNVR)?

The reporting person, John P. Vivona, serves as Executive Vice President & Chief Risk Officer of Hanover Bancorp, Inc. His Form 4 filing reflects an equity-based compensation grant in the form of restricted common stock subject to time-based vesting.

Was cash paid for the Hanover Bancorp (HNVR) restricted stock grant?

No cash was paid for the restricted stock grant; the 1,338 shares were reported at a transaction price of $0.0000 per share. This indicates the award was part of compensation rather than a market purchase of Hanover Bancorp common stock.